NovoCure Limited (NVCR)

NovoCure Limited (NVCR) is a healthcare company (medical devices) based in Switzerland. The share price is $11.14, down 1.42% on the day, which values the company at $1.3B. Price as of 17 Nov 2026, 21:05 UTC, from Yahoo Finance.

Key facts

Share price
$11.14−1.42% today
Market value
$1.3B
Funk Score
35/100
Against its own history
Well below its usual priceusual price $66.93
200-week average
$22.8651% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

NovoCure Limited in more detail

NVCR trades at -15.3× next year's expected earnings, 1.8× sales. Measured against its own history, the price is 83% below what its usual multiples would imply ($66.93) — well below its usual price. It sits 51% below its 200-week average of $22.86.

Over the last five fiscal years NovoCure Limited has compounded revenue 5.8% a year. Its Funk Score is 35 out of 100 (financial strength 3.3, profitability 0.2, growth 5.4, value 5.0, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

NovoCure Limited (NVCR): questions and answers

What is NovoCure Limited's market cap?

NovoCure Limited is valued at $1.3B at a share price of $11.14.

Is NVCR overvalued or undervalued?

Against its own history, NVCR is well below its usual price: the price is 83% below the $66.93 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is NVCR above its 200-week moving average?

No. NVCR is 51.3% below its 200-week average of $22.86. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is NovoCure Limited growing?

Over the last five fiscal years NovoCure Limited's revenue grew 5.8% a year; over ten years revenue grew 34.8% a year.

Does NVCR pay a dividend?

NovoCure Limited does not currently pay a regular dividend.

Cite this page

Funkfolio, “NovoCure Limited (NVCR) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/NVCR

Underlying data: Yahoo Finance; company filings with the SEC.